| Dr Jeffrey Steele, MD | |
|
416 E Monroe St, Ste 200, South Bend, IN 46601-2371 | |
| (574) 232-8119 | |
| Not Available |
| Full Name | Dr Jeffrey Steele |
|---|---|
| Gender | Male |
| Speciality | Anesthesiology |
| Experience | 18 Years |
| Location | 416 E Monroe St, South Bend, Indiana |
| Accepts Medicare Assignments | May be. He may accept the Medicare-approved amount; you may be billed for more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1497912844 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207L00000X | Anesthesiology | 01066737A (Indiana) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Saint Joseph Regional Medical Center | Mishawaka, IN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Saint Joseph Regional Medical Center-south Bend Campus Inc | 3476451790 | 77 |
| The South Bend Clinic Llc | 3779577937 | 174 |
News Archive
A new study from researchers at the University of Cincinnati (UC) and the Cincinnati Department of Veterans Affairs Medical Center reaffirms that some patients with HIV experience an improved quality of life following their diagnosis.
Pfizer Inc. announced today the U.S. Food and Drug Administration (FDA) has approved BOSULIF (bosutinib), an Abl and Src kinase inhibitor, for the treatment of adult patients with chronic, accelerated, or blast phase Philadelphia chromosome-positive (Ph+) chronic myelogenous leukemia (CML) with resistance, or intolerance to prior therapy.
A patient's very own skin cells may hold the key to new treatments and even cures for devastating neurological diseases. A generous $1 million donation from Mr. J. Sebastian van Berkom, and critical partnerships with Brain Canada, Laval University, Marigold Foundation and the FRQS-Réseau Parkinson Quebec are driving an innovative, iPSC (induced pluripotent stem cell) research platform that will transform research into Parkinson's and other neurological diseases.
A new study from researchers at the University of Alabama at Birmingham (UAB) is one of the first to study the relationship between exercise and stroke in a large biracial cohort of men and women in the United States. The findings are published in the American Heart Association journal Stroke.
There is no evidence that blood pressure lowering drugs increase the risk of cancer, according to the most extensive study conducted on the topic. The late breaking research is presented today at ESC Congress 2020.
› Verified 4 days ago
| Entity Name | Beacon Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1033161617 PECOS PAC ID: 1254243306 Enrollment ID: O20031105000657 |
News Archive
A new study from researchers at the University of Cincinnati (UC) and the Cincinnati Department of Veterans Affairs Medical Center reaffirms that some patients with HIV experience an improved quality of life following their diagnosis.
Pfizer Inc. announced today the U.S. Food and Drug Administration (FDA) has approved BOSULIF (bosutinib), an Abl and Src kinase inhibitor, for the treatment of adult patients with chronic, accelerated, or blast phase Philadelphia chromosome-positive (Ph+) chronic myelogenous leukemia (CML) with resistance, or intolerance to prior therapy.
A patient's very own skin cells may hold the key to new treatments and even cures for devastating neurological diseases. A generous $1 million donation from Mr. J. Sebastian van Berkom, and critical partnerships with Brain Canada, Laval University, Marigold Foundation and the FRQS-Réseau Parkinson Quebec are driving an innovative, iPSC (induced pluripotent stem cell) research platform that will transform research into Parkinson's and other neurological diseases.
A new study from researchers at the University of Alabama at Birmingham (UAB) is one of the first to study the relationship between exercise and stroke in a large biracial cohort of men and women in the United States. The findings are published in the American Heart Association journal Stroke.
There is no evidence that blood pressure lowering drugs increase the risk of cancer, according to the most extensive study conducted on the topic. The late breaking research is presented today at ESC Congress 2020.
› Verified 4 days ago
| Entity Name | Saint Joseph Regional Medical Center-south Bend Campus Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1841245594 PECOS PAC ID: 3476451790 Enrollment ID: O20031223000724 |
News Archive
A new study from researchers at the University of Cincinnati (UC) and the Cincinnati Department of Veterans Affairs Medical Center reaffirms that some patients with HIV experience an improved quality of life following their diagnosis.
Pfizer Inc. announced today the U.S. Food and Drug Administration (FDA) has approved BOSULIF (bosutinib), an Abl and Src kinase inhibitor, for the treatment of adult patients with chronic, accelerated, or blast phase Philadelphia chromosome-positive (Ph+) chronic myelogenous leukemia (CML) with resistance, or intolerance to prior therapy.
A patient's very own skin cells may hold the key to new treatments and even cures for devastating neurological diseases. A generous $1 million donation from Mr. J. Sebastian van Berkom, and critical partnerships with Brain Canada, Laval University, Marigold Foundation and the FRQS-Réseau Parkinson Quebec are driving an innovative, iPSC (induced pluripotent stem cell) research platform that will transform research into Parkinson's and other neurological diseases.
A new study from researchers at the University of Alabama at Birmingham (UAB) is one of the first to study the relationship between exercise and stroke in a large biracial cohort of men and women in the United States. The findings are published in the American Heart Association journal Stroke.
There is no evidence that blood pressure lowering drugs increase the risk of cancer, according to the most extensive study conducted on the topic. The late breaking research is presented today at ESC Congress 2020.
› Verified 4 days ago
| Entity Name | The South Bend Clinic Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1073680419 PECOS PAC ID: 3779577937 Enrollment ID: O20040412000439 |
News Archive
A new study from researchers at the University of Cincinnati (UC) and the Cincinnati Department of Veterans Affairs Medical Center reaffirms that some patients with HIV experience an improved quality of life following their diagnosis.
Pfizer Inc. announced today the U.S. Food and Drug Administration (FDA) has approved BOSULIF (bosutinib), an Abl and Src kinase inhibitor, for the treatment of adult patients with chronic, accelerated, or blast phase Philadelphia chromosome-positive (Ph+) chronic myelogenous leukemia (CML) with resistance, or intolerance to prior therapy.
A patient's very own skin cells may hold the key to new treatments and even cures for devastating neurological diseases. A generous $1 million donation from Mr. J. Sebastian van Berkom, and critical partnerships with Brain Canada, Laval University, Marigold Foundation and the FRQS-Réseau Parkinson Quebec are driving an innovative, iPSC (induced pluripotent stem cell) research platform that will transform research into Parkinson's and other neurological diseases.
A new study from researchers at the University of Alabama at Birmingham (UAB) is one of the first to study the relationship between exercise and stroke in a large biracial cohort of men and women in the United States. The findings are published in the American Heart Association journal Stroke.
There is no evidence that blood pressure lowering drugs increase the risk of cancer, according to the most extensive study conducted on the topic. The late breaking research is presented today at ESC Congress 2020.
› Verified 4 days ago
| Entity Name | Southeast Anesthesiologists, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1548210685 PECOS PAC ID: 6800837980 Enrollment ID: O20050518001265 |
News Archive
A new study from researchers at the University of Cincinnati (UC) and the Cincinnati Department of Veterans Affairs Medical Center reaffirms that some patients with HIV experience an improved quality of life following their diagnosis.
Pfizer Inc. announced today the U.S. Food and Drug Administration (FDA) has approved BOSULIF (bosutinib), an Abl and Src kinase inhibitor, for the treatment of adult patients with chronic, accelerated, or blast phase Philadelphia chromosome-positive (Ph+) chronic myelogenous leukemia (CML) with resistance, or intolerance to prior therapy.
A patient's very own skin cells may hold the key to new treatments and even cures for devastating neurological diseases. A generous $1 million donation from Mr. J. Sebastian van Berkom, and critical partnerships with Brain Canada, Laval University, Marigold Foundation and the FRQS-Réseau Parkinson Quebec are driving an innovative, iPSC (induced pluripotent stem cell) research platform that will transform research into Parkinson's and other neurological diseases.
A new study from researchers at the University of Alabama at Birmingham (UAB) is one of the first to study the relationship between exercise and stroke in a large biracial cohort of men and women in the United States. The findings are published in the American Heart Association journal Stroke.
There is no evidence that blood pressure lowering drugs increase the risk of cancer, according to the most extensive study conducted on the topic. The late breaking research is presented today at ESC Congress 2020.
› Verified 4 days ago
| Entity Name | Clinical Colleagues Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1992725766 PECOS PAC ID: 8729011333 Enrollment ID: O20181101000420 |
News Archive
A new study from researchers at the University of Cincinnati (UC) and the Cincinnati Department of Veterans Affairs Medical Center reaffirms that some patients with HIV experience an improved quality of life following their diagnosis.
Pfizer Inc. announced today the U.S. Food and Drug Administration (FDA) has approved BOSULIF (bosutinib), an Abl and Src kinase inhibitor, for the treatment of adult patients with chronic, accelerated, or blast phase Philadelphia chromosome-positive (Ph+) chronic myelogenous leukemia (CML) with resistance, or intolerance to prior therapy.
A patient's very own skin cells may hold the key to new treatments and even cures for devastating neurological diseases. A generous $1 million donation from Mr. J. Sebastian van Berkom, and critical partnerships with Brain Canada, Laval University, Marigold Foundation and the FRQS-Réseau Parkinson Quebec are driving an innovative, iPSC (induced pluripotent stem cell) research platform that will transform research into Parkinson's and other neurological diseases.
A new study from researchers at the University of Alabama at Birmingham (UAB) is one of the first to study the relationship between exercise and stroke in a large biracial cohort of men and women in the United States. The findings are published in the American Heart Association journal Stroke.
There is no evidence that blood pressure lowering drugs increase the risk of cancer, according to the most extensive study conducted on the topic. The late breaking research is presented today at ESC Congress 2020.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Jeffrey Steele, MD 416 E Monroe St, Ste 200, South Bend, IN 46601-2371 Ph: (574) 232-8119 | Dr Jeffrey Steele, MD 416 E Monroe St, Ste 200, South Bend, IN 46601-2371 Ph: (574) 232-8119 |
News Archive
A new study from researchers at the University of Cincinnati (UC) and the Cincinnati Department of Veterans Affairs Medical Center reaffirms that some patients with HIV experience an improved quality of life following their diagnosis.
Pfizer Inc. announced today the U.S. Food and Drug Administration (FDA) has approved BOSULIF (bosutinib), an Abl and Src kinase inhibitor, for the treatment of adult patients with chronic, accelerated, or blast phase Philadelphia chromosome-positive (Ph+) chronic myelogenous leukemia (CML) with resistance, or intolerance to prior therapy.
A patient's very own skin cells may hold the key to new treatments and even cures for devastating neurological diseases. A generous $1 million donation from Mr. J. Sebastian van Berkom, and critical partnerships with Brain Canada, Laval University, Marigold Foundation and the FRQS-Réseau Parkinson Quebec are driving an innovative, iPSC (induced pluripotent stem cell) research platform that will transform research into Parkinson's and other neurological diseases.
A new study from researchers at the University of Alabama at Birmingham (UAB) is one of the first to study the relationship between exercise and stroke in a large biracial cohort of men and women in the United States. The findings are published in the American Heart Association journal Stroke.
There is no evidence that blood pressure lowering drugs increase the risk of cancer, according to the most extensive study conducted on the topic. The late breaking research is presented today at ESC Congress 2020.
› Verified 4 days ago
Dr. Fahimulla Z Shariff, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 416 E Monroe St, Suite 200, South Bend, IN 46601 Phone: 574-232-8119 Fax: 574-288-0235 | |
Dr. Bryan R Wipperman, M.D. Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 416 E Monroe St, Suite 200, South Bend, IN 46601 Phone: 574-232-8119 Fax: 574-288-0235 | |
Dr. Ike Van Trinh, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 416 E Monroe St, Suite 200, South Bend, IN 46601 Phone: 574-232-8119 Fax: 574-288-0235 | |
Shane Michael Ditty, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 416 E Monroe St, Ste. 200, South Bend, IN 46601 Phone: 574-232-8119 Fax: 574-288-0235 | |
Dr. Ryan R. Sorrell, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 416 E Monroe St, Suite 200, South Bend, IN 46601 Phone: 574-232-8119 Fax: 574-288-0235 | |
Daniel M Cooke, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 416 E Monroe St, Suite 200, South Bend, IN 46601 Phone: 574-232-8119 Fax: 574-288-0235 | |
Theresa R. Cruthird, M.D. Anesthesiology Medicare: Medicare Enrolled Practice Location: 121 S Saint Louis Blvd, South Bend, IN 46617 Phone: 574-233-3123 Fax: 574-233-3125 |